Literature DB >> 17715420

Prognosis in heart failure with a normal ejection fraction.

John G F Cleland, Jacqueline Taylor, Michal Tendera.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17715420     DOI: 10.1056/NEJMc076179

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Rick A Nishimura; Paul Sorajja; Carolyn S P Lam; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2010-06-11       Impact factor: 8.790

2.  Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide.

Authors:  Nadezhda Glezeva; Patrick Collier; Victor Voon; Mark Ledwidge; Kenneth McDonald; Chris Watson; John Baugh
Journal:  J Cardiovasc Transl Res       Date:  2013-04-27       Impact factor: 4.132

Review 3.  Evaluation and management of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Nat Rev Cardiol       Date:  2020-03-30       Impact factor: 32.419

4.  Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study.

Authors:  Otto Kamp; Marco Metra; Gilles W De Keulenaer; Burkert Pieske; Viviane Conraads; José Zamorano; Lieven Huysse; Panos E Vardas; Michael Böhm; Livio Dei Cas
Journal:  Clin Res Cardiol       Date:  2009-12-29       Impact factor: 5.460

5.  Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome.

Authors:  Husam M Abdel-Qadir; Shaan Chugh; Douglas S Lee
Journal:  Int J Nephrol       Date:  2011-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.